TADALAFIL 2.5 MG TABLET

tadalafil
$0.1227per EA

Strength

2.5 mg/1

NDC

62332017715

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA204809

On Market Since

3/26/2019

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price History

1W

0.0%

1M

-2.5%

3M

+1.1%

6M

-1.5%

1Y

-10.8%

3Y

-27.4%

5Y

-39.1%

All

-98.4%